|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | (2017.08) |
| A61K 47/60 | (2017.01) | ||
| A61K 47/61 | (2017.01) | ||
| A61K 47/61 | (2017.08) | ||
| A61K 38/14 | (2013.01) | ||
| A61K 38/55 | (2013.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 21/04 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3439702 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17719409.9 |
| Date of filing the European patent application | 2017-04-04 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/026001 |
| Date | 2017-04-04 |
| (87) | Number | WO 2017/176798 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 201662318003 P | 2016-04-04 | US |
| (72) |
HOLMES, Kevin , US
NORTON, Angela, W. , US
PAN, Clark , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF |
| CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF |